RxDoctor Payments DataLook up a doctor →

Percy Lee, MD

Radiation Oncology · Irvine, CANPI 1447442504

Payments from drug & device makers

$2,399,765in general payments, 2019–2025

Across 127 payments — averaging $18,896 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2.3M
  • Viewray Technologies Inc$41K
  • Siemens Medical Solutions USA, Inc.$27K
  • GE HealthCare$22K
  • Varian Medical Systems, Inc.$8K
  • F. Hoffmann-la Roche AG$8K
  • plus $9K from 12 others
$17,365in research payments, 2019–2025

Across 10 payments — averaging $1736.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$11K
  • Viewray Technologies Inc$7K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,399,765 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$568,934
Medicare patients
312
Services billed
4,612

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →